What is Hilo?
Hilo, formerly Aktiia, was founded in 2018 with the mission to revolutionize blood pressure monitoring and management. The company leverages advanced AI algorithms and extensive datasets to provide cuffless blood pressure monitoring (CBPM) products. These products offer convenient and valuable reports for both individuals and healthcare professionals, delivering a comprehensive view of blood pressure trends. Hilo's foundational model for blood pressure has been trained on billions of optical signals and hundreds of millions of readings from over 120,000 users, establishing its leadership in the CBPM sector.
How much funding has Hilo raised?
Hilo has raised a total of $36M across 2 funding rounds:
Other Financing Round
$6M
Other Financing Round
$30M
Other Financing Round (2020): $6M, investors not publicly disclosed
Other Financing Round (2024): $30M led by TransLink Capital, Molten, Khosla Ventures, and Redalpine
Key Investors in Hilo
TransLink Capital
Translink Capital is a venture capital firm based in Silicon Valley, specializing in connecting technology companies with Asia's leading multinationals. They focus on investments from Seed to Series B, particularly in sectors like Artificial Intelligence and Cyber Security.
Molten
Molten Corporation specializes in a diverse range of products including sports equipment, automotive parts, and medical welfare devices, demonstrating a commitment to innovation across various sectors.
Khosla Ventures
Khosla Ventures is a prominent venture capital firm known for its investments in technology and sustainability, often backing transformative companies at various stages of growth.
What's next for Hilo?
With the recent major strategic investment, Hilo is poised to accelerate its growth and further develop its cutting-edge CBPM technology. This funding will likely support expanded research and development, enhance manufacturing capabilities, and facilitate broader market penetration. The company's focus on integrating AI with user data suggests a future trajectory aimed at providing more personalized and predictive healthcare solutions, potentially disrupting traditional diagnostic methods in cardiovascular health.
See full Hilo company page
